focus -WSS

focus

author：hotspot 2025-09-03 11:49:25 - browse：98129

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Congenital heart disease patients face new threat of heart failure

WSS

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Pfizer plans to depart BIO

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

explore

The cancer drug shortage isn’t new — and neither are the solutions

In medicine, common shorthands can shortchange care

As demand for Covid shots wanes, Moderna seeks its next success

Spinal cord stimulation reduces pain in amputees, study finds

Alkermes shareholders re

Democratic lawmaker calls for 'well

How to save PrEP access — and even expand it

'The Exorcist' director William Friedkin dead at 87

Medicare proposal to cover medical devices draws a mixed reaction

At least 12 people were injured in a blast at a port in northwest Turkey

focus

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

'The Exorcist' director William Friedkin dead at 87

Leukemia patients are helped by Syndax's new type of therapy

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Chemotherapy shortages won’t get better under Biden’s latest plan

Pregnancy discrimination could be enabled by AI

explore

Wikipedia

Wikipedia

entertainment